Evidence map›Paper›PMID 29212943›Full record

ArticleJournal of virology2018

The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers.

Joseph Newman, Amin S Asfor, Stephen Berryman, Terry Jackson, Stephen Curry, Tobias J Tuthill

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph NewmanThe Pirbright Institute, Pirbright, Surrey, United Kingdom.
Amin S AsforThe Pirbright Institute, Pirbright, Surrey, United Kingdom.
Stephen BerrymanThe Pirbright Institute, Pirbright, Surrey, United Kingdom.
Terry JacksonThe Pirbright Institute, Pirbright, Surrey, United Kingdom.
Stephen CurryDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Tobias J TuthillThe Pirbright Institute, Pirbright, Surrey, United Kingdom toby.tuthill@pirbright.ac.uk.
The Pirbright Institute · GBImperial College London · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00001411Biotechnology and Biological Sciences Research Council BBS/E/I/00001577Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Biotechnology and Biological Sciences Research Council BBS/E/I/00007037Biotechnology and Biological Sciences Research Council BBS/E/I/00007039
6 · The paper itself

Abstract

Productive picornavirus infection requires the hijacking of host cell pathways to aid with the different stages of virus entry, synthesis of the viral polyprotein, and viral genome replication. Many picornaviruses, including foot-and-mouth disease virus (FMDV), assemble capsids via the multimerization of several copies of a single capsid precursor protein into a pentameric subunit which further encapsidates the RNA. Pentamer formation is preceded by co- and posttranslational modification of the capsid precursor (P1-2A) by viral and cellular enzymes and the subsequent rearrangement of P1-2A into a structure amenable to pentamer formation. We have developed a cell-free system to study FMDV pentamer assembly using recombinantly expressed FMDV capsid precursor and 3C protease. Using this assay, we have shown that two structurally different inhibitors of the cellular chaperone heat shock protein 90 (hsp90) impeded FMDV capsid precursor processing and subsequent pentamer formation. Treatment of FMDV permissive cells with the hsp90 inhibitor prior to infection reduced the endpoint titer by more than 10-fold while not affecting the activity of a subgenomic replicon, indicating that translation and replication of viral RNA were unaffected by the drug.

Indexed as

Virus Assembly3C Viral ProteasesAnimalsBenzoquinonesCapsid ProteinsCell-Free SystemCell LineCell SurvivalCricetinaeCysteine EndopeptidasesFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusHSP90 Heat-Shock ProteinsIsoxazolesLactams, MacrocyclicMolecular Chaperones17-(dimethylaminoethylamino)-17-demethoxygeldanamycin3C Viral Proteases5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamideBenzoquinonesCapsid ProteinsCysteine EndopeptidasesHSP90 Heat-Shock ProteinsIsoxazolesLactams, MacrocyclicMolecular ChaperonesProtein PrecursorsResorcinolsRNA, ViralViral Proteinsfoot-and-mouth disease virushsp90picornaviruspolyprotein processingvirus assembly

Identifiers

PMID29212943
PMCPMC5809743
OpenAlexW2774978823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.